CN Patent

CN121127461A — 二氢噻吩并嘧啶类化合物、其制备方法和应用

Assigned to Shanghai Yidi Biotechnology Co ltd · Expires 2025-12-12 · 0y expired

What this patent protects

涉及一种二氢噻吩并嘧啶类化合物、其制备方法和应用，属于生物医药领域。具体的，涉及通式(I)所示的化合物、其制备方法及含有该化合物的药物组合物，及其在制备治疗炎性疾病、自身免疫性疾病、代谢疾病和神经系统疾病及相关疾病药物中的应用。

USPTO Abstract

涉及一种二氢噻吩并嘧啶类化合物、其制备方法和应用，属于生物医药领域。具体的，涉及通式(I)所示的化合物、其制备方法及含有该化合物的药物组合物，及其在制备治疗炎性疾病、自身免疫性疾病、代谢疾病和神经系统疾病及相关疾病药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN121127461A
Jurisdiction
CN
Classification
—
Expires
2025-12-12
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Yidi Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.